DR REDDY'S | Ascending Triangle — Watch ₹1,415 BreakoutOverview
Dr. Reddy's Laboratories — one of India's leading pharmaceutical companies — is forming a well-defined Ascending Triangle on the Daily chart. Today's strong +2.11% session pushed price to ₹1,390, approaching the key resistance at ₹1,415, before closing at ₹1,374. The triangle structure remains intact and the breakout zone is approaching.
The Ascending Triangle
An Ascending Triangle forms when price makes higher lows (rising trendline below) while repeatedly testing a flat horizontal resistance above. This pattern signals accumulation — buyers are consistently stepping in at higher levels, pushing price toward the resistance ceiling.
Upper Boundary: Flat resistance at ₹1,415 — tested multiple times since 2024. Sellers have defended this level consistently. This is the key breakout trigger.
Lower Boundary: Rising trendline support connecting the lows from April 2025 through February 2026 — confirming buyers are making higher lows over time.
Today's Price Action — Why This Setup is Timely
Today's +2.11% session saw Dr. Reddy's rally to ₹1,390 — approaching but not yet breaking the ₹1,415 resistance. Price closed at ₹1,374, consolidating within the triangle structure. The ascending triangle remains fully intact.
The stock is in the compression zone — the narrowing space between rising support and flat resistance — where the next directional move is building energy.
The EMA Context
📈 50 EMA at ₹1,300 — price trading well above, confirming medium-term bullish momentum.
📈 200 EMA at ₹1,273 — price above the 200 EMA, confirming the long-term trend remains bullish.
Both EMAs are positioned as support layers below — adding depth to the bullish structure.
Key Levels
🔴 Triangle Upper Resistance — 1,415 (breakout trigger)
🟡 Current Price — 1,374 (inside triangle)
🟢 50 EMA Support — 1,300
🟢 200 EMA Support — 1,273
🟢 Rising Trendline Support — dynamic, rising from April 2025 lows
🎯 Measured Move Target — 1,820 (triangle height ₹400 projected from breakout at 1,415)
🔴 Invalidation — close below rising trendline
Two Scenarios
🟢 Scenario A — Breakout Confirms
Price breaks above ₹1,415 on a daily close with good volume. This confirms the Ascending Triangle breakout. First interim target is ₹1,600+, with a measured move target of ₹1,820 (triangle height of ~₹400 projected upward from the breakout level).
🔴 Scenario B — Resistance Holds, Pullback
Price fails to break above ₹1,415 and pulls back toward the rising trendline support. The triangle structure remains valid as long as price holds above the rising trendline. A close below the trendline would invalidate the pattern — watch the 50 EMA at ₹1,300 as the next support.
Beginner's Lesson — What is an Ascending Triangle?
An Ascending Triangle tells a story of shifting power from sellers to buyers:
The flat resistance shows sellers defending the same price level repeatedly
The rising trendline shows buyers becoming more aggressive — unwilling to wait for lower prices
As the two lines converge, pressure builds inside the pattern
Eventually buyers overwhelm sellers — and the breakout happens
The key insight: the pattern is bullish not because of the breakout, but because of the higher lows forming before it. Each higher low is a sign buyers are getting stronger.
Always wait for a confirmed daily close above ₹1,415 before acting — not just an intraday breach.
Conclusion
Dr. Reddy's is forming a clean Ascending Triangle on the Daily chart. The upper resistance at ₹1,415 is the key level — multiple tests, multiple rejections. But the rising trendline below shows buyers getting stronger with each pullback.
Watch for a daily close above ₹1,415 with volume — that is the confirmation signal.
For educational purposes only. Not financial advice. Always manage your risk.
PHARMA
SEQUENT SCIENTIFIC By KRS Charts8th May 2025 / 10:30 AM
Why SEQUENT SCIENTIFIC?
1. Technically it is showing Potential for movement.
2. In Past Already Got More than 50% Returns but important thing is as per Dow Theory it is making Higher Low.
3. In 1D TF multiple Breakouts with Above avg Volume is visible.
4. This is 1M Time Frame , so View is Medium to Long term.
T1 is already Achieved in Past but again after Retracement T1 & T2 will be same as before from current price.
AMANTA: Weekly Rounding Base Breakout1. The Macro Perspective: The Structural Rounding Base
I am taking a LONG bias on Amanta Healthcare Limited (AMANTA) on the macro weekly (1W) timeframe. Following a prolonged corrective phase in late 2025, the stock spent several months carving out a textbook "U-shaped" rounding accumulation base. This extended digestion period is highly constructive; it flushed out weak hands and allowed institutional capital to systematically absorb overhead supply before initiating this fresh markup phase.
2. The Educational Setup: Horizontal Boundaries
To understand the technical validity behind this move, look closely at how the price structure interacted with its core boundary:
The 147.48 Resistance Ceiling: The definitive line in the sand for a bullish structural phase transition was the solid black horizontal resistance line drawn at 147.48. This critical supply zone marked the peak of the previous major structure on the left side of the chart and served as the absolute lid on the rounding base.
3. Current Price Action: Breakout and Extreme Volume Expansion
The structural pressure cooker has officially exploded. Looking at the right side of the chart, buyers stepped in with overwhelming conviction last week, supported by a massive, towering surge in weekly trading volume that completely dwarfs all historical volume bars on this chart. The stock printed a powerful green expansion candle that decisively obliterated the 147.48 macro ceiling. It is currently showing excellent continuation, trading exceptionally strong at 160.39. The stock has officially transitioned out of its multi-month accumulation structure and into a highly explosive markup trend.
4. The Trade Plan: Entries, Targets, and Risk Management
Entry Strategy: Momentum is firmly established. While chasing an extended weekly move carries a minor risk of a short-term lower-timeframe mean-reversion pullback, the highest-probability strategy is to look to scale into long positions on any potential structural retest of the broken 145.00 to 150.00 prior resistance zone. Letting old historical resistance prove itself as a concrete new support floor provides an unmatched risk-to-reward ratio.
Targets: By utilizing a classical measured move strategy based on the maximum structural depth of the massive rounding base (measuring from the deep lows roughly around 95.00 up to the 147.48 ceiling), we project an expansion of approximately 50+ points. Projecting this upward from the breakout point, our primary structural macro target sits comfortably in the 200.00 to 210.00 zone over the coming quarters.
Risk Management: This structural breakout thesis is invalidated if the price fails to sustain its newly claimed floor and collapses back deep inside the core of the rounding base. A hard stop loss should be placed safely below the recent breakout structure and accumulation cluster, specifically around the 125.00 to 130.00 level.
5. Time Horizon:
Because this technical setup captures a clean structural phase transition and a massive rounding base breakout on the 1-Week chart backed by undeniable institutional volume, this is a long-term position trade designed to capture a sustained secular markup phase. Let the trend run!
TORNTPHARM: Classic Cup and Handle Breakout1. The Macro Perspective: The Cup and Handle Formation
I am taking a LONG bias on Torrent Pharmaceuticals Ltd. (TORNTPHARM) on the daily (1D) timeframe. This is a quintessential "Cup and Handle" continuation pattern, which is one of the most reliable structures for identifying a continuation of a primary uptrend. The "Cup" represents a prolonged period of consolidation where supply was systematically absorbed, and the "Handle" acts as the final low-volatility shakeout before the explosive move higher.
2. The Educational Setup: Defining the Structure
To understand the technical validity behind this launch, look at the two distinct phases:
The Cup (Rounding Bottom): This formation indicates that the stock has finished its corrective phase and buyers have regained control. The rounded bottom shows a gradual return of demand.
The Handle: Following the cup, the stock consolidated in a tight range (the handle). This is crucial, as it allows the stock to digest the previous gains and reset the momentum indicators for the next leg up.
The Breakout Line: The black horizontal resistance line drawn at approximately 4,500 served as the "neckline" of the pattern. A decisive close above this level effectively confirms the completion of the pattern.
3. Current Price Action: Breakout Confirmation
The price has officially cleared the handle and is currently trading at 4,655.90. This breakout indicates that the structural pressure has been released. The market is now shifting from accumulation to active markup. The breakout is visually confirmed by the recent price action pushing above the previous resistance, signaling that the momentum is now firmly in the hands of the bulls.
Note: Always verify your EOD data to ensure the breakout holds through the final market close.
4. The Trade Plan: Entries, Targets, and Risk Management
Entry Strategy: Momentum is currently strong. For those who missed the initial breakout, a high-probability strategy is to look for a "retest" entry. If the price pulls back slightly to retest the 4,500 – 4,550 zone, it provides an excellent risk-to-reward opportunity as old resistance becomes new support.
Take Profit (Targets): In a Cup and Handle pattern, we use a measured move strategy based on the depth of the cup. Projecting the height of the cup upward from the breakout point, our primary target sits in the 5,000 to 5,200 zone over the medium term.
Invalidation (Stop Loss): This bullish thesis is invalidated if the stock fails to sustain its breakout and drops back into the handle or cup. A hard stop loss should be placed below the handle, specifically around the 4,200 to 4,250 level. A close back inside the handle would signal a failure of the pattern.
5. Time Horizon:
Because this technical setup captures a clean structural continuation pattern on the 1-Day chart, this is a high-alpha swing trade designed to capture the next phase of the trend. Let the trend run!
SUPRIYA: Monthly Macro Range Breakout1. The Macro Perspective: The Multi-Year Accumulation Base
I am taking a LONG bias on Supriya Lifescience Limited (SUPRIYA) on the macro monthly (1M) timeframe
When analyzing pure market structure on a pharma sector stock, extended accumulation bases are critical for initiating the next leg of a secular markup. Following a steep corrective phase after its initial listing, the stock entered a massive structural consolidation spanning several years, carving out a highly defined rectangular base. This digestion phase absorbed overhead supply and allowed institutional capital to quietly accumulate shares at steady valuations. Documenting these classical accumulation bases makes the charting workflow highly repeatable and easy to understand for any new trainees joining the research desk.
2. The Educational Setup: Horizontal Resistance & Structural Support
To understand the technical validity behind this macro launch, look closely at how the price structure interacted with its core boundaries:
The 819.85 Resistance Ceiling: The definitive line in the sand for a bullish structural shift was the top solid black horizontal resistance line drawn at 819.85. This level established a massive supply zone that systematically capped upward momentum over the past year.
The 557.15 Structural Support: During the consolidation, buyers established clear support near the 557.15 zone, marked by the lower horizontal line. The price action oscillated cleanly between these two boundaries, gradually flushing out weak hands and building immense kinetic energy.
3. Current Price Action: Breakout and Volatility Expansion
Look at the most recent monthly candle on the far right of the chart. The structural pressure cooker has officially exploded. Institutional buyers have stepped in with undeniable conviction. The stock printed a towering, full-bodied green expansion candle that has decisively obliterated the 819.85 multi-year ceiling, currently trading incredibly strong near 949.00. The stock has officially transitioned out of macro accumulation and into a highly explosive markup trend into fresh territory.
Note: Because this is a monthly timeframe, ensure all end-of-month data has fully synchronized. Remember that evening exchange data synchronization delays can occasionally alter the visual confirmation of these critical breakout wicks, so always double-check the final shape before confirming the setup.
4. The Trade Plan: Entries, Targets, and Risk Management
Entry Strategy: Macro momentum is exceptionally strong with the stock trading vertically out in the open above the pivotal breakout line. Chasing an extended monthly breakout candle carries a minor risk of a lower-timeframe mean-reversion pullback. The highest-probability, lowest-risk entry strategy involves stepping down to the daily or weekly timeframe and waiting for the initial vertical excitement to cool off. Look to scale into long positions on a potential structural pullback to perfectly retest the broken 800.00 to 830.00 prior resistance zone. Letting old historical resistance prove itself as a concrete new support floor provides an unmatched risk-to-reward ratio.
Take Profit (Targets): By utilizing a classical measured move strategy based on the structural depth of the accumulation base, we can project upside targets. Taking the approximate depth of the macro base (roughly 260 points from the 557.15 floor up to the 819.85 ceiling) and projecting it upward from the breakout point, our primary structural macro target sits comfortably in the 1,050.00 to 1,100.00 zone over the coming quarters.
Invalidation (Stop Loss): An explosive macro breakout thesis is completely invalidated if the price fails to hold its newly claimed structural floor and collapses back inside the core of the base boundaries. A hard stop loss should be placed safely below the recent lower-timeframe swing lows, specifically around the 700.00 to 730.00 level. A definitive monthly close completely back below 700.00 would act as a severe warning sign of a failed macro breakout and a major bull trap.
5. Time Horizon:
Because this technical setup captures a clear structural phase transition and a major horizontal breakout on the 1-Month chart, this is a long-term position trade designed to capture a sustained secular markup phase over the coming months and quarters. Let the macro trend run!
WOCKPHARMA: Monthly Macro Breakout1. The Macro Perspective: The Multi-Year Consolidation Base
I am taking a LONG bias on Wockhardt Limited (WOCKPHARMA) on the macro monthly (1M) timeframe.
When analyzing pure market structure on a pharmaceutical leader, massive accumulation bases are critical for initiating long-term secular trends. Following a significant markdown phase and subsequent accumulation, WOCKPHARMA entered a massive structural bottoming process spanning several years. This sideways consolidation effectively absorbed profit-taking and allowed institutional capital to quietly accumulate shares over an extended period. Fundamentally, this technical momentum aligns perfectly with Wockhardt's blockbuster Q4 FY26 earnings report and monumental clinical milestones. The company reported a strong turnaround in its March quarter, moving back into profitability with a Profit Before Tax of ₹189 crore compared to a loss in the previous year. Quarterly revenue jumped 30% year-on-year to ₹965 crore, and EBITDA surged by an incredible 147%. Additionally, the company recently received a massive catalyst: the US Food and Drug Administration (FDA) and India's Central Drugs Standard Control Organisation (CDSCO) both approved its breakthrough antibiotic, Zaynich, for complicated urinary tract infections, sparking a massive surge in investor demand.
2. The Educational Setup: Horizontal Boundary Defense
To understand the technical validity behind this macro launch, look closely at how the price structure interacted with its core boundaries prior to breaking out:
The 1,842.35 Resistance Ceiling: The definitive line in the sand for a bullish structural shift was the solid black horizontal resistance line drawn at 1,842.35. This level established a massive supply zone over previous years that systematically capped upward momentum.
The Dynamic Launchpad: During the multi-year consolidation, institutional buyers stepped in to carve out a massive rounding recovery and subsequent higher lows. This squeezed volatility directly beneath the breakout zone, building immense kinetic energy.
3. Current Price Action: Breakout and Volatility Expansion
Look at the most recent monthly candle on the far right of the chart. The structural pressure cooker has officially exploded. Driven by the blowout earnings and the monumental Zaynich approvals, institutional buyers have stepped in with undeniable conviction. The stock printed a massive, full-bodied green expansion candle that has decisively obliterated the 1,842.35 multi-year ceiling, currently trading incredibly strong near 2,031.40. The stock has officially transitioned out of low-volatility accumulation and into a highly explosive markup trend into fresh territory.
4. The Trade Plan: Entries, Targets, and Risk Management
Entry Strategy: Macro momentum is exceptionally strong with the stock trading vertically out in the open. Chasing an extended monthly breakout candle carries a minor risk of a short-term, lower-timeframe mean-reversion pullback. The highest-probability, lowest-risk entry strategy involves stepping down to the weekly or daily timeframe and waiting for the initial vertical excitement to cool off. Look to scale into long positions on a potential structural pullback to perfectly retest the broken 1,750.00 to 1,850.00 prior resistance zone. Letting old historical resistance prove itself as a concrete new support floor provides an unmatched risk-to-reward ratio.
Take Profit (Targets): Because the stock is clearing a major multi-year structure to launch into pure price discovery, we use a classical measured move strategy based on the depth of the accumulation base. By taking the approximate depth of the macro range and projecting it upward from the breakout point, our primary structural macro target sits comfortably in the 2,600.00 to 2,800.00 zone over the coming quarters.
Invalidation (Stop Loss): An explosive macro breakout thesis is completely invalidated if the price fails to hold its newly claimed structural floor and collapses back inside the core of the base boundaries. A hard stop loss should be placed safely below the recent lower-timeframe swing lows and the mid-level of the breakout, specifically around the 1,450.00 to 1,500.00 level. A definitive monthly close completely back below 1,450.00 would act as a severe warning sign of a failed macro breakout and a major bull trap.
5. Time Horizon:
Because this technical setup is built on a 1-Month chart capturing a clear structural phase transition and a major horizontal breakout, this is a longer-term position trade designed to capture a rapid momentum markup phase over the coming months. Let the macro trend run!
Wockhardt Q4 FY26 Financial Highlights
This summary provides a detailed breakdown of the massive revenue growth and EBITDA expansion driving this structural momentum.
CNXPHARMA - a broad sectorial analysisNSE:CNXPHARMA (Mid term View)
Price above EMA/s
Resistance Tested
Price action shows Strength
Various stocks of its composition showing good vibe one by one
NSE:PHARMABEES
NSE:SUNPHARMA (Sector weightage ~22%)
Price above EMA/s
2 Trendline b/o already done
Ready to break consolidation Range
NSE:DIVISLAB (Sector weightage ~ 10%)
Price above all EMA/s
Price range narrow down and shrinking
Range breakout possible soon
NSE:DRREDDY (Sector weightage ~ 9%)
Price above all EMA/s
Hidden absorption area confirm further
Price give b/o with sector up move or bounce back from daily demand zone price b/o
NSE:LUPIN (Sector weightage ~ 6.5%) and NSE:TORNTPHARM (Sector weightage ~ 5.5%)
Already in strong up move
NSE:AUROPHARMA (Sector weightage ~ 4%)
Already broken weekly resistance and give clear close above on daily
Many others stocks of this sector to be watch are as follow
NSE:BIOCON NSE:RUBICON NSE:CORONA NSE:JBCHEPHARM NSE:MANKIND NSE:AKUMS
NB: Not a Registered Advisor. Many time I failed with my setups. Do take advise from your financial advisor prior trade. Here I am just sharing my views to community, not recommended anyone to buy or sell.
Natco Pharma - Enough CorrectionCMP 875 on 22.05.25
The stock price dropped 50% between September 2024 and March 2025. In recent days, it has been consolidating near the 800 levels, which is acting as a support zone, as shown on the chart.
MACD shows a likely crossover, too.
If it gives an upside move, further targets may be 1080/1180 or more.
One has to keep the position size according to the risk management.
The setup will go weak if it sustains below 800-775 levels.
All these illustrations are only for learning and sharing purposes, not a piece of trading advice in any way.
All the best.
Emcure Pharmaceuticals (NSE:EMCURE) BreakoutThe Emcure Pharmaceuticals gave a breakout in a weekly timeframe from the zone(red zone) of 1595-1597. It is trying to give retest at the crucial juncture of 1595 again, but as the breakout was not supported by enough volumes hence, the stock will come back to the trendline (yellow line) and again try to give a breakout above 1595. If the breakout sustains on weekly timeframe and is supported by strong volumes, then the stock would rally 50% directly to 2400 price target. The target was chosen by measuring the April 2025 low to the current top of 1597 using price and data range indicator.
Fundamentally speaking, the company has all time high profits, all time high revenue, the margins have now normalized and as a part of earnings perspective the stock is a turnaround story. The company is expanding it's capacity at a stable rate, maintaining a healthy debt to equity ratio. The concerning part is accounts receivables (which has shot up to above 2000 levels in 2024 and the trend is increasing for under 6 month receivables) and inventory days which has although decreased from 293 in 2021 to 225 in 2025, but is still a concern. There is a sector tailwind for the Pharmaceutical sector in India due to the mention of making India a Biopharma manufacturing hub in the Union Budget of 2026, hence that gives an increase in probability of stock to perform well over 3-5 year time horizon.
Ajanta Pharma Limited Daily Chart📊 Current Price
Approx LTP: ₹2,850 – ₹2,890 range on NSE daily chart.
📈 Ajanta Pharma — 1 Day Key Levels
🔹 Pivot Point
Pivot: ₹2,835.57
🔹 Resistance Levels
R1: ₹2,883.13
R2: ₹2,913.57
R3: ₹2,961.13
🔹 Support Levels
S1: ₹2,805.13
S2: ₹2,757.57
S3: ₹2,727.13
📉 Moving Average Levels (Daily)
10-EMA: ₹2,888
20-EMA: ₹2,882
50-EMA: ₹2,865
100-EMA: ₹2,847
200-EMA: ₹2,820
👉 Price trading above most moving averages, showing short-term bullish momentum.
📊 Momentum Indicators
RSI: ~60 → bullish strength
CCI: ~119 → strong upside momentum
ADX: ~50 → strong trend present
🎯 Important Trading Zones
Bullish breakout: Above ₹2,913 → target ₹2,960 – ₹3,000
Buy on dip zone: ₹2,800 – ₹2,830
Bearish breakdown: Below ₹2,755 → downside toward ₹2,720
EMCUREEMCURE showing very good strength in recent times. Least affected sector in this war situation is Pharma! Once it closes above this resistance zone then the probability of 25-30% run is quite possible from hereon provided that it sustain above that level. once it closes one can keep that 1580 as a support. Seems quite attractive with RR quite in favor. Market participation is also observed which may confirm the trend.
WOCKPHARMAWOCKPHARMA is not so much attractive but is available at very low risk-reward. Considering current war like situation the sector which is going to affect very less is pharma & health sector. So even in this panic selling they are not participating. On lower side 1230 seems to be very strong support. But once it gets momentum the stock has a potential to go above 1700 levels. Keep in yr watch list.
CIPLA – 1D | Demand Reaction + Trendline Confluence Setup
After a strong impulsive decline from the 1520 supply zone, price tapped into the major daily demand (1280–1315) and is now consolidating above a rising trendline support.
We’re seeing early signs of base formation right at higher timeframe demand — a critical reaction zone.
📌 Setup Overview:
Entry Zone: 1330–1360 (pullback / breakout confirmation area)
Stop Loss: Below 1280 demand
Target: 1480–1520 supply
R:R: ~1:5 structure-based opportunity
Price is compressing below minor resistance while respecting trendline support — a breakout above 1360–1380 can trigger momentum toward the 1480+ liquidity zone.
🔹 Bullish bias valid as long as 1280 holds.
🔹 Breakdown below demand invalidates structure and opens lower levels.
High timeframe demand + trendline confluence = decision zone.
Trade the reaction, not the prediction.
Risk management is key.
Cipla - Positional LongCMP 1342 on 11.02.26
All important levels are marked on the chart.
The range between 1280 and 1330 appears to be a support level. The price is sustaining and consolidating here. If it goes up. may go to the levels of 1425/1480/1550.
The setup fails if the price sustains below 1280-1270.
The above illustration is only for learning and sharing purposes, not a buy or sell recommendation.
All the best.
AlbertDavid - At supportsCMP 752.70 on 05.01.26
All important levels are marked on the chart. The stock price is on the 5-year-old support levels. If it bounces from these levels, it may go into a bullish phase. Possible targets may be 900/1000/1100, and even more, depending on forthcoming parameters.
The setup fails if the price sustains below the 720-710 levels.
The risk-reward ratio is quite good at the moment.
One must determine the position size according to the risk capacity. Always keep your stop-loss confirmed.
All these illustrations are only for educational and learning purposes, it should not be considered as a buy or sell recommendation. Please do your research before any trade or consult your financial advisor.
All the best.
Biocon breaks out of 4-year consolidationStructure: Breakout from a long-term 4-year consolidation base
Volume: Strong expansion indicating institutional participation
Momentum:
RSI > 70 and holding → bullish trend zone
MACD positive and rising → trend confirmation
Trend:
9 EMA > 21 EMA > 200 EMA → multi-timeframe trend alignment
Sector Strength:
Pharma sector outperforming (Sun Pharma, JB Chem, Lupin, Biocon)
Broad-based buying visible across sector
Bias: Bullish as long as price sustains above breakout levels
Invalidation: Close back below breakout zone or loss of EMA/MACD trend
Ajanta Pharma at a Critical Point | Breakout or RejectionAjanta Pharma is currently trading around the ₹2800 mark, which has acted as a strong resistance zone over the past few months. The stock has tested this level 4 to 5 times, indicating significant supply pressure and trader interest at this price point.
At this stage, Ajanta Pharma stands at a crucial inflection point:
📈 Bullish Scenario:
A clean breakout above ₹2800, especially with volume confirmation, could potentially lead to a 10% upside in the near term, with scope for a 20% rally if momentum sustains.
📉 Bearish Scenario:
However, if the stock fails to break through and faces rejection again, we might see a pullback of around 10%, as traders book profits or short near resistance.
This setup presents a high-reward trade opportunity with a well-defined risk level, making it a good candidate to keep on your watchlist.
Disclaimer:
This post is for educational and informational purposes only. I am not a SEBI-registered investment advisor or research analyst. Please do your own research or consult a certified financial advisor before making any investment decisions.
ABBOTINDIA Swing Trade ( 10% upside potential) Abbott India is near to the previous Institutional Buying zone and has upside potential of 10%.
Simple Demand Zone buying setup.
Don't keep hard stop loss. Manage positions as per situation.
Follow for more such setups.
I have been very busy lately because of renovation at home. Will be sharing more setups soon. Thanks.






















